Alatrach, Mariam
Laichuthai, Nitchakarn
Martinez, Robert
Agyin, Christina
Ali, Ali Muhammed
Al-Jobori, Hussein
Lavynenko, Olga
Adams, John
Triplitt, Curtis
DeFronzo, Ralph https://orcid.org/0000-0002-8581-6273
Cersosimo, Eugenio
Abdul-Ghani, Muhammad
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors (Results)
https://doi.org/10.2337/db19-0770
Documents that mention this clinical trial
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors (Results)
https://doi.org/10.2337/db19-0770
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-107680)